Clinical Efficacy and Safety of Sodium Thiosulfate in the Treatment of Uremic Pruritus: A Meta-Analysis of Randomized Controlled Trials

Uremic pruritus is a distressful complication of chronic kidney disease and results in impaired quality of life and higher mortality rates. Intravenous sodium thiosulfate has been reported to alleviate pruritus in hemodialysis patients. We performed a systematic review and meta-analysis to estimate...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ping-Hsun Lu, Hui-En Chuo, Ko-Lin Kuo, Jian-Fu Liao, Po-Hsuan Lu
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
R
Acceso en línea:https://doaj.org/article/4d665e2c5b4942bdbb029106bbfb4ef3
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4d665e2c5b4942bdbb029106bbfb4ef3
record_format dspace
spelling oai:doaj.org-article:4d665e2c5b4942bdbb029106bbfb4ef32021-11-25T19:08:41ZClinical Efficacy and Safety of Sodium Thiosulfate in the Treatment of Uremic Pruritus: A Meta-Analysis of Randomized Controlled Trials10.3390/toxins131107692072-6651https://doaj.org/article/4d665e2c5b4942bdbb029106bbfb4ef32021-10-01T00:00:00Zhttps://www.mdpi.com/2072-6651/13/11/769https://doaj.org/toc/2072-6651Uremic pruritus is a distressful complication of chronic kidney disease and results in impaired quality of life and higher mortality rates. Intravenous sodium thiosulfate has been reported to alleviate pruritus in hemodialysis patients. We performed a systematic review and meta-analysis to estimate the efficacy of intravenous sodium thiosulfate in patients with uremic pruritus. A systematic search of electronic databases up to June 2021 was conducted for randomized controlled trials that evaluated the clinical effects of sodium thiosulfate in the management of patients with uremic pruritus. Two reviewers selected eligible articles and evaluated the risk of bias; the results of pruritus assessment and uremic pruritus-related laboratory parameters in selected studies were analyzed. There are four trials published between 2018 and 2021, which include 222 participants. The sodium thiosulfate group displayed significant decrease in the pruritus score (standardized mean difference = −3.52, 95% confidence interval = −5.63 to −1.41, <i>p</i> = 0.001), without a significant increase in the adverse effects (risk ratio = 2.44, 95% confidence interval = 0.37 to 15.99, <i>p</i> = 0.35) compared to the control group. Administration of sodium thiosulfate is found to be a safe and efficacious complementary therapy in improving uremic pruritus in patients with chronic kidney disease.Ping-Hsun LuHui-En ChuoKo-Lin KuoJian-Fu LiaoPo-Hsuan LuMDPI AGarticleuremic pruritussodium thiosulfatechronic kidney diseaseadverse drug reactionMedicineRENToxins, Vol 13, Iss 769, p 769 (2021)
institution DOAJ
collection DOAJ
language EN
topic uremic pruritus
sodium thiosulfate
chronic kidney disease
adverse drug reaction
Medicine
R
spellingShingle uremic pruritus
sodium thiosulfate
chronic kidney disease
adverse drug reaction
Medicine
R
Ping-Hsun Lu
Hui-En Chuo
Ko-Lin Kuo
Jian-Fu Liao
Po-Hsuan Lu
Clinical Efficacy and Safety of Sodium Thiosulfate in the Treatment of Uremic Pruritus: A Meta-Analysis of Randomized Controlled Trials
description Uremic pruritus is a distressful complication of chronic kidney disease and results in impaired quality of life and higher mortality rates. Intravenous sodium thiosulfate has been reported to alleviate pruritus in hemodialysis patients. We performed a systematic review and meta-analysis to estimate the efficacy of intravenous sodium thiosulfate in patients with uremic pruritus. A systematic search of electronic databases up to June 2021 was conducted for randomized controlled trials that evaluated the clinical effects of sodium thiosulfate in the management of patients with uremic pruritus. Two reviewers selected eligible articles and evaluated the risk of bias; the results of pruritus assessment and uremic pruritus-related laboratory parameters in selected studies were analyzed. There are four trials published between 2018 and 2021, which include 222 participants. The sodium thiosulfate group displayed significant decrease in the pruritus score (standardized mean difference = −3.52, 95% confidence interval = −5.63 to −1.41, <i>p</i> = 0.001), without a significant increase in the adverse effects (risk ratio = 2.44, 95% confidence interval = 0.37 to 15.99, <i>p</i> = 0.35) compared to the control group. Administration of sodium thiosulfate is found to be a safe and efficacious complementary therapy in improving uremic pruritus in patients with chronic kidney disease.
format article
author Ping-Hsun Lu
Hui-En Chuo
Ko-Lin Kuo
Jian-Fu Liao
Po-Hsuan Lu
author_facet Ping-Hsun Lu
Hui-En Chuo
Ko-Lin Kuo
Jian-Fu Liao
Po-Hsuan Lu
author_sort Ping-Hsun Lu
title Clinical Efficacy and Safety of Sodium Thiosulfate in the Treatment of Uremic Pruritus: A Meta-Analysis of Randomized Controlled Trials
title_short Clinical Efficacy and Safety of Sodium Thiosulfate in the Treatment of Uremic Pruritus: A Meta-Analysis of Randomized Controlled Trials
title_full Clinical Efficacy and Safety of Sodium Thiosulfate in the Treatment of Uremic Pruritus: A Meta-Analysis of Randomized Controlled Trials
title_fullStr Clinical Efficacy and Safety of Sodium Thiosulfate in the Treatment of Uremic Pruritus: A Meta-Analysis of Randomized Controlled Trials
title_full_unstemmed Clinical Efficacy and Safety of Sodium Thiosulfate in the Treatment of Uremic Pruritus: A Meta-Analysis of Randomized Controlled Trials
title_sort clinical efficacy and safety of sodium thiosulfate in the treatment of uremic pruritus: a meta-analysis of randomized controlled trials
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/4d665e2c5b4942bdbb029106bbfb4ef3
work_keys_str_mv AT pinghsunlu clinicalefficacyandsafetyofsodiumthiosulfateinthetreatmentofuremicpruritusametaanalysisofrandomizedcontrolledtrials
AT huienchuo clinicalefficacyandsafetyofsodiumthiosulfateinthetreatmentofuremicpruritusametaanalysisofrandomizedcontrolledtrials
AT kolinkuo clinicalefficacyandsafetyofsodiumthiosulfateinthetreatmentofuremicpruritusametaanalysisofrandomizedcontrolledtrials
AT jianfuliao clinicalefficacyandsafetyofsodiumthiosulfateinthetreatmentofuremicpruritusametaanalysisofrandomizedcontrolledtrials
AT pohsuanlu clinicalefficacyandsafetyofsodiumthiosulfateinthetreatmentofuremicpruritusametaanalysisofrandomizedcontrolledtrials
_version_ 1718410213996888064